Teva Pharmaceuticals has officially launched generic liraglutide injections in the United States. Novo Nordisk currently sells liraglutide under the brand name Victoza.

MR imaging could provide insight into how Parkinson’s disease will progress years before its related symptoms become debilitating.  

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.

Daily sleep disruptions could increase the risk of developing Alzheimer’s disease in the future, new research suggests. 

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

The newly approved DeepRhythm Platform from Medicalgorithmics uses advanced AI to evaluate imaging results and look for signs of cardiac arrhythmias.

The Cordella platform from Endotronix includes an implantable sensor that tracks the patient’s PA pressure and other helpful health data.

“Understanding the sex differences in obesity-related HFpEF is of great importance,” one cardiologist explained. “Obesity and visceral adiposity are key drivers of HFpEF development and progression, and this may be even more amplified in women."